TL;DR
- Many major skin cell populations express oestrogen receptors — including keratinocytes, fibroblasts, melanocytes, sebaceous gland cells, and hair follicle cells
- Oestrogen upregulates collagen synthesis, increases hyaluronic acid production, reduces sebum, supports barrier function, and modulates melanocyte activity
- Trans women start from a male-pattern baseline — the trajectory of skin change on HRT is different from postmenopausal women, and the research largely reflects the latter
- Oestrogen may increase susceptibility to hyperpigmentation in those with genetic predisposition and significant UV exposure — but this is not inevitable
- Skin changes begin within weeks but structural changes take years — most skincare advice is not written with transfeminine hormonal change in mind
Your skin is not a passive surface. It is a hormonally active organ that has been functioning in an androgen-dominant hormonal environment throughout your pre-transition life. When oestrogen levels rise following HRT initiation, skin cells respond at the receptor level — and the changes are structural, not cosmetic.
Many major skin cell populations express oestrogen receptors — specifically ERα and ERβ, the two main oestrogen receptor subtypes. These include dermal fibroblasts, epidermal keratinocytes, melanocytes, sebaceous gland cells, and hair follicle cells, though receptor density and subtype predominance vary considerably across compartments. ERβ is the predominant oestrogen receptor in scalp skin specifically; in other compartments such as dermal fibroblasts and sebaceous glands, both subtypes are typically co-expressed without one clearly dominating, and in some pathological skin contexts ERα can be the dominant functional receptor for specific outcomes. Rising oestrogen levels alter signalling through these receptors, contributing to a range of structural and functional changes in the skin.
Collagen and skin thickness
The most clinically significant effect is on collagen. Oestrogen stimulates collagen synthesis by dermal fibroblasts, reduces the activity of collagen-degrading matrix metalloproteinases (MMPs), and influences collagen remodelling and extracellular matrix homeostasis. In some studies of postmenopausal women on HRT, skin thickness increased by approximately 7–15% compared to untreated controls — though these figures derive from specific cohorts, often using topical oestrogen, and should be understood as indicative rather than precise.
An important nuance for trans women specifically: most of the skin thickness data comes from postmenopausal cisgender women, who are starting from a female baseline. Trans women start from a male-pattern baseline — thicker, more sebaceous skin with different dermal characteristics and sebum physiology. On feminising HRT, the trajectory is not simply “skin gets thicker” but rather a shift in dermal structure, sebum pattern, and skin texture toward female-typical characteristics. This involves relative thinning from the male baseline in some parameters alongside improvements in hydration and elasticity. The net change is complex, and the postmenopausal literature does not fully describe it.
Hyaluronic acid and hydration
Oestrogen increases hyaluronic acid synthesis in the dermis. Hyaluronic acid is a glycosaminoglycan with exceptional water-binding capacity and is the primary driver of dermal hydration and turgor. Experimental data show substantial increases in hyaluronic acid synthesis with oestrogen administration, with corresponding increases in dermal water content. This likely contributes to the changes in skin texture and perceived plumpness that many trans women commonly describe in the early months of HRT.
Sebum and oiliness
Sebaceous glands express oestrogen receptors, and oestrogen reduces sebum production. The reduction in skin oiliness that many trans women experience on HRT reflects direct oestrogenic action on sebocytes, compounded by reduced androgenic stimulation as testosterone suppression takes effect. Androgens — particularly DHT — are potent stimulators of sebaceous gland activity. Both sides of the hormonal shift contribute to reduced sebum output.
Barrier function
Oestrogen influences epidermal barrier integrity through multiple mechanisms: it helps maintain ceramide homeostasis, promotes epidermal thickening, accelerates wound healing, and reduces transepidermal water loss (TEWL). As testosterone falls and oestrogen rises, changes in sebum and barrier lipid composition can transiently increase skin dryness and sensitivity — particularly in the first months of HRT before the skin has adapted to its new hormonal environment. This is clinically relevant: skin may feel more reactive during early HRT than after hormonal adaptation has occurred, and skincare routines should account for this.
Melanocytes and pigmentation
Oestrogen influences melanocyte activity and may increase susceptibility to hyperpigmentation disorders such as melasma, particularly in individuals with genetic predisposition and significant UV exposure. This is well-documented in pregnancy and with oestrogen-containing oral contraceptives, both of which are high-oestrogen states. However, melasma is not an inevitable consequence of HRT — many trans women never develop clinically significant hyperpigmentation. Daily photoprotection is important for this reason, and also for photoageing prevention and skin cancer risk — reasons that apply regardless of HRT status.
Timeline and expectations
Skin changes begin within the first weeks to months of HRT. Early changes in sebum and hydration are often noticeable within the first one to three months. Collagen and structural changes are slower, typically requiring sustained oestrogen exposure over 12–24 months for meaningful differences. The skin continues to change for years.
Most skincare advice is not written with transfeminine hormonal changes in mind. It either addresses androgen-dominant skin or postmenopausal skin — neither of which fully captures the trajectory of skin on feminising HRT. Understanding what oestrogen actually does at the cellular level is the starting point for making sense of what your skin needs at each stage.
⚠️ Clinical note: Most quantitative data on oestrogen’s effects on skin derives from postmenopausal cisgender women, with some data from topical oestrogen studies. The cellular mechanisms are well-established; specific magnitudes should be understood as approximate. Trans women starting from a male-pattern skin baseline may experience a different trajectory than these studies describe.
Sources
- Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol. 2002;11(6):487–502.
- Thornton MJ, Taylor AH, Mulligan K, et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol. 2003;12(2):181–190.
- Viscomi B, Muniz M, Sattler S. Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement. J Cosmet Dermatol. 2025;24(Suppl 4):e70393.
- Hardman MJ, Ashcroft GS. Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly. Genome Biol. 2008;9(5):R80.
- Yeung H, Kahn B, Ly BC, Tangpricha V. Dermatologic Conditions in Transgender Populations. Endocrinol Metab Clin North Am. 2019;48(2):429–440.
